483
Brio Pharmaceuticals IncBrio Pharmaceuticals Inc – FDA 483, Jan 24, 2020
Record Details
An FDA inspection of Woodfield Pharmaceutical, LLC in Houston, TX, revealed significant deficiencies within its quality control unit. The firm failed to adequately implement procedures for investigating out-of-specification environmental monitoring results, including the presence of gram-negative organisms. Additionally, the company did not properly follow its temperature and humidity monitoring program for manufacturing rooms, failing to document temperature excursions.
View Company Profile
ID · 8a324c13-c0cb-47bb-9009-6c5849d9d466
Other documents for Brio Pharmaceuticals Inc
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.